135 related articles for article (PubMed ID: 2512655)
21. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
Panteleeva GP; Mikhaĭlova NM; Beliaev BS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
[TBL] [Abstract][Full Text] [Related]
22. Steady-state lithium blood level fluctuations in man following administration of a lithium carbonate conventional and controlled-release dosage form.
Caldwell HC; Westlake WJ; Schriver RC; Bumbier EE
J Clin Pharmacol; 1981; 21(2):106-9. PubMed ID: 6785324
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of lithium adverse effects between a short-term (Quilonum) and a depot preparation (Lithium Duriles)].
Matussek N; von Hessling P
Nervenarzt; 1971 Jul; 42(7):376-8. PubMed ID: 5561070
[No Abstract] [Full Text] [Related]
24. A comparison of pharmacokinetic versus empirical lithium dosing techniques.
Browne JL; Huffman CS; Golden RN
Ther Drug Monit; 1989; 11(2):149-54. PubMed ID: 2497563
[TBL] [Abstract][Full Text] [Related]
25. [Compliance with and tolerance of sustained-release lithium carbonate].
Lavantes B; Senimon F; Bayle FJ
Encephale; 1999; 25(2):152-7. PubMed ID: 10370888
[TBL] [Abstract][Full Text] [Related]
26. Practicality of a lithium dosing guide.
Naiman IF; Muniz CE; Stewart RB; Yost RL
Am J Psychiatry; 1981 Oct; 138(10):1369-71. PubMed ID: 7294197
[TBL] [Abstract][Full Text] [Related]
27. Single-dose bioavailability of two extended-release lithium carbonate products.
Kirkwood CK; Wilson SK; Hayes PE; Barr WH; Sarkar MA; Ettigi PG
Am J Hosp Pharm; 1994 Feb; 51(4):486-9. PubMed ID: 8017413
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a slow-release lithium carbonate formulation.
Cooper TB; Simpson GM; Lee JH; Bergner PE
Am J Psychiatry; 1978 Aug; 135(8):917-22. PubMed ID: 665833
[TBL] [Abstract][Full Text] [Related]
29. Accuracy and safety of a priori lithium loading.
Kook KA; Stimmel GL; Wilkins JN; Spangher GG
J Clin Psychiatry; 1985 Feb; 46(2):49-51. PubMed ID: 3918024
[TBL] [Abstract][Full Text] [Related]
30. A pharmacokinetic analysis of lithium carbonate absorption from several formulations in man.
Caldwell HC; Westlake WJ; Connor SM; Flanagan T
J Clin Pharmacol New Drugs; 1971; 11(5):349-56. PubMed ID: 5208514
[No Abstract] [Full Text] [Related]
31. [Long-term treatment of bipolar disorder: how should we use lithium salts?].
Del Grande C; Muti M; Musetti L; Pergentini I; Corsi M; Turri M; Soldani I; Corsini GU; Dell'Osso L
Riv Psichiatr; 2012; 47(6):515-26. PubMed ID: 23160112
[TBL] [Abstract][Full Text] [Related]
32. Comparison of plasma lithium levels and their interindividual variations with coated lithium carbonate tablets and a medium-slow-release lithium sulphate preparation (Lithionit Duretter).
Persson G
Acta Psychiatr Scand; 1977 Feb; 55(2):147-52. PubMed ID: 320831
[TBL] [Abstract][Full Text] [Related]
33. Prediction of lithium carbonate dosage in psychiatric inpatients using the repeated one-point method.
Marr MA; Djuric PE; Ritschel WA; Garver DL
Clin Pharm; 1983; 2(3):243-8. PubMed ID: 6411413
[TBL] [Abstract][Full Text] [Related]
34. Three cases of severe mania successfully treated with high-dosage lithium-carbonate.
Thau K; Meszaros K; Simhandl C
Pharmacopsychiatry; 1991 May; 24(3):85-8. PubMed ID: 1909797
[TBL] [Abstract][Full Text] [Related]
35. [Renal clearance technic for individualizing lithium dosage in routine hospital care].
Klinger E; Steimer JL; Jouvent R; Le Moël G; Mascart JY; Des Lauriers A
Encephale; 1984; 10(5):223-30. PubMed ID: 6440774
[TBL] [Abstract][Full Text] [Related]
36. Does lithium dose prediction improve treatment efficiency? Prospective evaluation of a mathematical method.
Markoff RA; King M
J Clin Psychopharmacol; 1992 Oct; 12(5):305-8. PubMed ID: 1479047
[TBL] [Abstract][Full Text] [Related]
37. [Lithium carbonate (Contemnol--Spofa). A clinical study].
Pirozynski T; Chiriţă V; Cosmovici N; Berlescu M; Luchian M; Gafencu A; Bălţatu M
Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):683-94. PubMed ID: 2517680
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of dosage schedules for delayed-action lithium carbonate].
Balon R; Kabesh Ia
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):264-6. PubMed ID: 6803477
[No Abstract] [Full Text] [Related]
39. Liberation of lithium from sustained release preparations. A comparison of seven registered brands.
Heim W; Oelschläger H; Kreuter J; Müller-Oerlinghausen B
Pharmacopsychiatry; 1994 Jan; 27(1):27-31. PubMed ID: 8159780
[TBL] [Abstract][Full Text] [Related]
40. Formulation and in vitro-in vivo evaluation of sustained-release lithium carbonate tablets.
Ciftçi K; Capan Y; Oztürk O; Hincal AA
Pharm Res; 1990 Apr; 7(4):359-63. PubMed ID: 2114020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
